Q3 2023 Novozymes A/S Earnings Call Transcript
Welcome to the Novozymes conference call regarding the interim report for the first 9 months of 2023. (Operator Instructions)
Today, I am pleased to leave the word to Tobias Cornelius Björklund, Head of Investor Relations. Please begin your meeting.
/-
Thank you, operator, and welcome, everyone, to Novozymes conference call for the first 9 months of 2023. My name is, as mentioned, Tobias Björklund, and I'm heading up Investor Relations here at Novozymes. At this call, our CEO, Ester Baiget; and our CFO, Lars Green, will review our performance and key events of the first 9 months of the year as well as the outlook for the full year. Also attending today's call are Tina Fanoe, EVP, Agriculture & Industrial Biosolutions; Amy Byrick, EVP, Strategy and Business Transformation; Anders Lund, EVP, Consumer Biosolutions; and Claus Fuglsang, CSO and EVP of Research and Development. Then entire call will take about 60 minutes, including time for questions at the end.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
